Chronic stable angina treatment

Chronic stable angina Microchapters
Acute Coronary Syndrome Main Page
Home
Patient Information
Overview
Historical Perspective
Classification
Classic Chronic Stable Angina
Atypical Walk through Angina Mixed Angina Nocturnal Angina Postprandial Angina Cardiac Syndrome X Vasospastic Angina
Differentiating Chronic Stable Angina from Acute Coronary Syndromes
Pathophysiology
Epidemiology and Demographics
Risk Stratification
Pretest Probability of CAD in a Patient with Angina
Prognosis
Diagnosis
History and Symptoms
Physical Examination
Test Selection Guideline for the Individual Basis
Laboratory Findings
Electrocardiogram
Exercise ECG
Chest X Ray
Myocardial Perfusion Scintigraphy with Pharmacologic Stress
Myocardial Perfusion Scintigraphy with Thallium
Echocardiography
Exercise Echocardiography
Computed coronary tomography angiography(CCTA)
Positron Emission Tomography
Ambulatory ST Segment Monitoring
Electron Beam Tomography
Cardiac Magnetic Resonance Imaging
Coronary Angiography
Treatment
Medical Therapy
Revascularization
PCI
CABG
Hybrid Coronary Revascularization
Alternative Therapies for Refractory Angina
Transmyocardial Revascularization (TMR)
Spinal Cord Stimulation (SCS)
Enhanced External Counter Pulsation (EECP)
ACC/AHA Guidelines for Alternative Therapies in patients with Refractory Angina
Discharge Care
Patient Follow-Up
Rehabilitation
Secondary Prevention
Guidelines for Asymptomatic Patients
Noninvasive Testing in Asymptomatic Patients
Risk Stratification by Coronary Angiography
Pharmacotherapy to Prevent MI and Death in Asymptomatic Patients
Landmark Trials
Case Studies
Case #1
Chronic stable angina treatment On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Chronic stable angina treatment
CDC onChronic stable angina treatment
Chronic stable angina treatment in the news
Blogs on Chronic stable angina treatment
to Hospitals Treating Chronic stable angina treatment
Risk calculators and risk factors for Chronic stable angina treatment

Editors-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Cafer Zorkun, M.D., Ph.D. [2]; Associate Editors-In-Chief: John Fani Srour, M.D.; Jinhui Wu, MD.

Identification and treatment of exacerbating conditions

• While chronic stable angina may be due to underlying atherosclerosis, other factors may either precipitate or exacerbate angina.

• Identification and management of these conditions may reduce the frequency and intesity of anginal episodes. These conditions include:

• Anemia,
• Uncontrolled hypertension,
• Thyroid disorders (thyrotoxicosis),
• Heart rhythm abnormalities (tachyarrhythmias),
• Decompensated congestive heart failure and
• Concomitant valvular heart disease.

Risk factor modification

• Initiation of intensive modification of risk factors is urgent and an essential part of the main therapy in chronic stable angina.

• Initiate risk factor modification, promote regular physical exercise (all patients should be encouraged to obtain 30 to 60 minutes/day of regular aerobic activity), low fat diet, and lifestyle modification.

• You can read in greater detail about each of the risk factor modification topic below by clicking on the link for that topic

Smoking Cessation | Weight Management | Physical Activity | Lipid management | BP control | Diabetes control | ACC/AHA Guidelines for Cardiovascular Risk Factor Reduction

The treatment essentials

Alphabet of chronic stable angina management: elements listed below are the most important components of stable angina management.

• A=Aspirin use
• A=Anti anginal therapy
• B=Beta blocker use
• B=Blood pressure control
• C=Cholesterol lowering therapy
• C=Cigarette smoking cessation
• D=Diabetes Mellitus control
• D=Diet
• E=Exercise
• E=Education

Pharmacotherapy

You can read in greater detail about each of the pharmacotherapy for chronic stable angina below by clicking on the link for that topic

• Overview of pharmacotherapy in patients with chronic stable angina

• Antiplatelet agents: Aspirin | Dipyridamole | Clopidogrel

• Antianginal agents: Nitrates | Beta Blockers | Calcium Channel Blockers | Newer Anti-anginal Agents

• ACEI/RAAS blockers

• Anti-lipid agents

• ACC/AHA Guidelines for Pharmacotherapy to prevent MI, Death and Reduce symptoms

Revascularization

• Revascularization is used only for select patients specially those who have uncontrolled symptoms with optimal medical therapy.

• This can be achieved with either percutaneous coronary intervention(PCI) with stent placement or coronary artery bypass surgery.

• In general, PCI is reserved for single or some cases of two vessel disease, and
• CABG is reserved for patients with two or three vessel disease or left main disease.

• With the availability of drug-eluting stents, PCI is increasingly being performed for many lesions including more complex ones.

• You can read in greater detail about specific revascularization approaches for the treatment of chronic stable angina by clicking on the link below for that topic.

PCI | CABG | PCI vs CABG | ACC/AHA Guidelines for Revascularization

Alternative therapies for refractory angina

• You can read in greater detail about each of the alternative therapies for refractory angina below by clicking on the link for that topic.

Transmyocardial Revascularization | Spinal Cord Stimulation | Enhanced External Counter Pulsation (EECP) | ACC/AHA Guidelines for Alternative Therapies in patients with Refractory Angina

See Also

• The Chronic Stable Angina Living Guidelines: Vote on current recommendations and suggest revisions to the guidelines

Sources

• The ACC/AHA/ACP–ASIM Guidelines for the Management of Patients With Chronic Stable Angina

• TheACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina

• The 2007 Chronic Angina Focused Update of the ACC/AHA 2002 Guidelines for the Management of Patients With Chronic Stable Angina

References

Template:WikiDoc Sources